Quality Control of MHC Class I Restricted Antigen Processing
MHC I 类限制性抗原加工的质量控制
基本信息
- 批准号:8662182
- 负责人:
- 金额:$ 39.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmino AcidsAminopeptidaseBindingCD8B1 geneCalnexinCell surfaceCell-Free SystemCellsComplexCytosolDisulfidesERp57Endoplasmic ReticulumEnzymesGenesGlucoseGlucosidase IIGlycoproteinsGoalsHLA-A geneHumanImmune responseIndividualLaboratoriesLectinLinkMHC Class I GenesMajor Histocompatibility ComplexMediatingMembraneMembrane GlycoproteinsModelingMolecularMolecular ChaperonesMusMutagenesisOxidoreductasePathway interactionsPeptidesPlayPolysaccharidesProcessProteinsQuality ControlRegulationRoleStructureSulfhydryl CompoundsSurfaceSystemT cell responseT-LymphocyteTAP1 geneTransferaseUridine Diphosphate GlucoseViral ProteinsVirusantigen processingantigenic peptide transporterbasecalreticulincell mediated immune responsedimerkillingspathogenpublic health relevancesmall moleculestoichiometrytapasin
项目摘要
DESCRIPTION (provided by applicant): Major Histocompatibility Complex (MHC) class I glycoproteins, the products of HLA-A, B and C genes in humans, are critical for T cell mediated immune responses to viruses and intracellular pathogens. They are glycoproteins that form a heterodimer with a small molecule, ?2-microglobulin (?2m), and associate in the endoplasmic reticulum (ER) of a cell with peptides derived from cellular proteins. These include, when the cell
is infected, pathogen-encoded proteins. Surface complexes of MHC class I molecules with pathogen-derived peptides are recognized by CD8-positive T cells that can kill the infected cell. The goal of this proposal is to understand the detailed molecular processes that result in the formation and cell surface expression of MHC class I complexes that contain peptides of extraordinarily high affinity, which is essential for CD8-T cell responses that can rid an infected
individual of the pathogen. Binding of peptides to MHC class I molecules occurs within a multi-protein assembly called the Peptide Loading Complex, or PLC. The PLC consists of MHC class I molecules themselves, a heterodimeric transporter called the Transporter associated with Antigen Processing (TAP) that delivers the peptides into the ER, tapasin, a membrane glycoprotein that, with a soluble molecule, ERp57, forms a disulfide-linked heterodimer that can mediate peptide exchange by the class I molecules to ultimately generate high affinity complexes, and a second soluble protein called calreticulin. The interactions responsible for the stability of the PLC involve specific associations of TAP and tapasin within the membrane, and between the luminal domains of tapasin and the MHC class I molecule. There are also interactions between ERp57 and calreticulin and a glycan-dependent interaction of the MHC class I glycoprotein with calreticulin that are shared by other folding glycoproteins in the ER. Th glycan structure is characteristically dynamically maintained by the action of two opposing enzymes, one, glucosidase II, that removes a terminal glucose residue, and a second, UDP-glucose glycoprotein transferase 1 (UGT1) that replaces the glucose when the glycoprotein bearing the glycan is improperly folded. This proposal seeks to determine the roles of these various interactions and enzymatic mechanisms in mediating the assembly of MHC class I molecules with high affinity peptides in the ER.
描述(由申请方提供):主要组织相容性复合物(MHC)I类糖蛋白是人类HLA-A、B和C基因的产物,对于T细胞介导的针对病毒和细胞内病原体的免疫应答至关重要。它们是与小分子形成异源二聚体的糖蛋白。2-微球蛋白(?2 m),并在细胞的内质网(ER)中与来源于细胞蛋白质的肽缔合。其中,当细胞
是被感染的病原体编码蛋白MHC I类分子与病原体衍生肽的表面复合物被CD 8阳性T细胞识别,其可以杀死感染的细胞。该提案的目标是了解导致MHC I类复合物形成和细胞表面表达的详细分子过程,该复合物含有非常高亲和力的肽,这对于可以清除感染的CD 8-T细胞应答是必需的。
病原体的个体。肽与MHC I类分子的结合发生在称为肽装载复合物或PLC的多蛋白质组装体中。PLC由MHC I类分子本身、将肽递送到ER中的称为与抗原加工相关的转运蛋白(TAP)的异二聚体转运蛋白、tapasin(一种膜糖蛋白,其与可溶性分子ERp 57形成二硫键连接的异二聚体,其可以介导I类分子的肽交换以最终产生高亲和力复合物)和称为钙网蛋白的第二可溶性蛋白组成。负责PLC稳定性的相互作用涉及TAP和tapasin在膜内的特异性结合,以及tapasin的管腔结构域和MHC I类分子之间的特异性结合。ERp 57和钙网蛋白之间也存在相互作用,以及MHC I类糖蛋白与钙网蛋白的聚糖依赖性相互作用,这些相互作用由ER中的其他折叠糖蛋白共享。聚糖结构的特征是通过两种相反的酶的作用动态地维持,一种是葡糖苷酶II,其去除末端葡萄糖残基,另一种是UDP-葡萄糖蛋白转移酶1(UGT 1),其在携带聚糖的糖蛋白不正确折叠时取代葡萄糖。该建议旨在确定这些各种相互作用和酶促机制在介导MHC I类分子与ER中的高亲和力肽的组装中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER CRESSWELL其他文献
PETER CRESSWELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER CRESSWELL', 18)}}的其他基金
SARS-CoV-2 infection and MHC class I function in bats
蝙蝠中的 SARS-CoV-2 感染和 MHC I 类功能
- 批准号:
10549369 - 财政年份:2022
- 资助金额:
$ 39.33万 - 项目类别:
SARS-CoV-2 infection and MHC class I function in bats
蝙蝠中的 SARS-CoV-2 感染和 MHC I 类功能
- 批准号:
10451136 - 财政年份:2022
- 资助金额:
$ 39.33万 - 项目类别:
Mechanisms of antigen cross-presentation by MHC class I molecules
MHC I 类分子的抗原交叉呈递机制
- 批准号:
10276760 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
Mechanisms of antigen cross-presentation by MHC class I molecules
MHC I 类分子的抗原交叉呈递机制
- 批准号:
10413224 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
Mechanisms of antigen cross-presentation by MHC class I molecules
MHC I 类分子的抗原交叉呈递机制
- 批准号:
10624950 - 财政年份:2021
- 资助金额:
$ 39.33万 - 项目类别:
The role of GILT in the generation of reactive oxygen species
GILT 在活性氧生成中的作用
- 批准号:
9091406 - 财政年份:2015
- 资助金额:
$ 39.33万 - 项目类别:
The role of GILT in the generation of reactive oxygen species
GILT 在活性氧生成中的作用
- 批准号:
8951439 - 财政年份:2015
- 资助金额:
$ 39.33万 - 项目类别:
Quality Control of MHC Class I Restricted Antigen Processing
MHC I 类限制性抗原加工的质量控制
- 批准号:
9925726 - 财政年份:2012
- 资助金额:
$ 39.33万 - 项目类别:
Quality Control of MHC Class I Restricted Antigen Processing
MHC I 类限制性抗原加工的质量控制
- 批准号:
9175668 - 财政年份:2012
- 资助金额:
$ 39.33万 - 项目类别:
Quality Control of MHC Class I Restricted Antigen Processing
MHC I 类限制性抗原加工的质量控制
- 批准号:
9275343 - 财政年份:2012
- 资助金额:
$ 39.33万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 39.33万 - 项目类别: